Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids

被引：0

作者：

Guttman-Yassky, E. ^{[1
]}

Weidinger, S. ^{[2
]}

Silverberg, J. ^{[3
]}

Gooderham, M. ^{[4
]}

Thyssen, J. ^{[5
]}

Irvine, A. ^{[6
]}

Elmaraghy, H. ^{[7
]}

Natalie, C. ^{[7
]}

Hu, C. ^{[7
]}

Pierce, E. ^{[7
]}

Gil, E. G. ^{[8
]}

Simpson, E. ^{[9
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA

[2] Univ Hosp SchleswigHolstein, Dept Dermatol & Allergy, Kiel, Germany

[3] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA

[4] Skin Ctr Dermatol, Peterborough, ON, Canada

[5] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark

[6] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland

[7] Eli Lilly & Co, Indianapolis, IN USA

[8] Almirall SA, Barcelona, Spain

[9] Oregon Hlth & Sci Univ, Portland, OR USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：S348 / S348

页数：1

共 50 条

[21] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Bridgeman, Sarah G.
Martino, Anna K.
Strowd, Lindsay C.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
[22] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Xu, Xinghua
Zheng, Yi
Zhang, Xin
He, Yanling
Li, Chengxin
[J]. ONCOTARGET, 2017, 8 (65) : 108480 - 108491
[23] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
Khattri, S.
Brunner, P. M.
Garcet, S.
Finney, R.
Cohen, S. R.
Oliva, M.
Dutt, R.
Fuentes-Duculan, J.
Zheng, X.
Li, X.
Bonifacio, K. M.
Kunjravia, N.
Coats, I.
Cueto, I.
Gilleaudeau, P.
Sullivan-Whalen, M.
Suarez-Farinas, M.
Krueger, J. G.
Guttman-Yassky, E.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
[24] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
Zhang, Jianzhong
Zhao, Yan
Zhou, Qinghong
Xu, Yuyu
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
[25] Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere) (vol 159, pg 182, 2023)
不详
[J]. JAMA DERMATOLOGY, 2023, 159 (09) : 1014 - 1014
[26] Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
Arents, Bernd W. M.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 694 - 694
[27] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
Murase, Jenny E.
Chovatiya, Raj
Strowd, Lindsay
Thyssen, Jacob P.
Bangert, Christine
Atwater, Amber Reck
Gallo, Gaia
Bardolet, Laia
Yang, Fan
Zhong, Jinglin
Staumont-Salle, Delphine
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[28] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
Cork, M. J.
Eichenfield, L. F.
Blauvelt, A.
Rosmarin, D.
Hussain, I.
Davis, J. D.
Li, M.
Zhang, Q.
Gadkari, A.
Eckert, L.
Kamal, M. A.
Bansal, A.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
[29] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
Guttman-Yassky, Emma
Okragly, Angela
Sun, Zhe
Mena, Laura Rebeca
Hahn, Nathan
Nickoloff, Brian J.
Siu, Kimberly
Gallo, Gaia
Wolf, Eric
Eyerich, Kilian
Aparici, Monica
Benschop, Robert J.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II4 - II5
[30] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
Guttman-Yassky, E.
Okragly, A.
Sun, Z.
Mena, L.
Hahn, N.
Nickoloff, B.
Siu, K.
Gallo, G.
Wolf, E.
Eyerich, K.
Aparici, M.
Benschop, R.
[J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)

← 1 2 3 4 5 →